Elise F. Nassif - Concepedia

Author

Elise F. Nassif

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

E Nassif, E. F. Nassif Haddad, E. Nassif, E.F. Nassif, E.F. Nassif Haddad, ENAD HADDAD, Elise F. Nassif Haddad, Elise F Nassif, Elise F Nassif Haddad, Elise F. Nassif

114

Publications

777

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Centre Léon Bérard Institut Gustave Roussy Centre de Recherche des Cordeliers Hôpital Européen Georges-Pompidou

About

Elise F. Nassif is an author at The University of Texas MD Anderson Cancer Center specializing in pathology, medicine, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	358
2	Pathology	7	7	358
3	Surgical Oncology	6	6	321
4	Health Sciences	1	1	36
5	Immunology	1	1	46

Elise F. Nassif

Publications

466

Citations

H-Index

Page 1

	Year	Citations
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial Neeta Somaiah, Anthony P. Conley, Edwin R. Parra, The Lancet Oncology Bone SarcomasSurgical OncologyMetastatic Soft TissueMedicineSingle-centre Phase 2	2022	140
Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients Charles Honoré, Jean‐Baptiste Delhorme, Elise F. Nassif, Surgical Oncology Surgical OncologyRetrospective Multicentric StudyTumoral PathologyGastrointestinal OncologyMedicine	2019	70
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma Christina L. Roland, Elise F. Nassif, Emily Z. Keung, Nature Cancer Surgical OncologyMedicineImmunologyNon-comparative Phase 2Pathology	2024	46
Etoposide and cisplatin salvage chemotherapy for small cell lung cancer J. A. Medina, J.M. Mann, Richard Grapski, Lung Cancer MedicineMetronomic TherapyPathologyBronchial NeoplasmCisplatin Salvage Chemotherapy	1985	37
<scp>Real‐world</scp> use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center Elise F. Nassif, Brandon Cope, Raymond Traweek, International Journal of Cancer Surgical OncologyCancer ManagementPathologySurgeryPharmacotherapy	2022	36
The immune landscape of undifferentiated pleomorphic sarcoma Rossana Lazcano, Carmélia Maria Noia Barreto, Ruth Salazar, Frontiers in Oncology	2022	24
Randomized phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS): Survival results after 2 years of follow-up and intratumoral B-cell receptor (BCR) correlates. Emily Z. Keung, Elise F. Nassif, Heather Lin, Journal of Clinical Oncology Surgical OncologyPathologyPhase Ii StudySurgeryTumor Biology	2022	19
The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival Elise F. Nassif, Bernhard Mlecnik, Constance Thibault, Cancers	2021	16
TP53 Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine Trials Elise F. Nassif, Édouard Auclin, Rastilav Bahleda, Cancers	2021	14
Disseminated Coccidioidomycosis Following COVID-19 Mimicking Metastatic Thoracic Relapse of Well-Differentiated Liposarcoma: A Case Report Elise F. Nassif, Nolan Maloney, Anthony P. Conley, Frontiers in Medicine	2021	12

Page 1